Literature DB >> 14598709

[Glutamate and gamma-aminobutylic acid release into the vitreous during cataract surgery].

Jun Kezuka1, Yoshihiro Wakabayashi, Tomoyuki Yagihashi, Takuya Iwasaki, Masahiko Usui.   

Abstract

OBJECTIVE: In cataract surgery, transient retinal ischemia and photostimulation-induced retinal damage occurs, even though only for a short duration. We suspected the possibility of excessive release of glutamate under these conditions, and therefore analyzed the amino acid contents in the vitreous body.
MATERIALS AND METHODS: The vitreous bodies of 32 eyes with disease of the macular area necessitating retinovitreous surgery were used as samples for amino acid analysis. Ischemic diseases such as diabetic retinopathy, venous occlusion, and retinal detachment were excluded. The vitreous amino acid contents were compared between 18 eyes that underwent combined cataract and vitreous surgery and 14 eyes that had vitreous surgery alone.
RESULTS: An approximately 3-fold increase of glutamate, 6-fold increase of gamma-aminobutylic acid (GABA), and 2-fold increase of alanine were observed in combined cataract and vitreous surgery compared to vitreous surgery alone.
CONCLUSION: Even in human eyes, acute pressure overload or photostimulation for a short duration cause excessive release of glutamate. A simultaneous increase of GABA suggests the possibility that when glutamate is over-released, the retina physiologically reduced the concentration of glutamate via GABA, in an attempt to suppress the neurotoxin action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598709

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  1 in total

1.  Dulbecco's Modified Eagle Medium is neuroprotective when compared to standard vitrectomy irrigation solution.

Authors:  Maximilian Schultheiss; Kai Januschowski; Hannah Ruschenburg; Charlotte Schramm; Sven Schnichels; Peter Szurman; K U Bartz-Schmidt; Martin S Spitzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-11       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.